Integra LifeSciences Holdings Corp (Nasdaq:IART) made a public announcement about the launch of Integra™ Allograft Cancellous Sponge.

The cancellous sponge affords excellent surgical flexibility. "The unique handling characteristics and biocompatibility of Integra™ Allograft Cancellous Sponge make it an ideal addition to Integra's portfolio of allografts and orthobiologics, and provide another flexible solution for improving patient care," said Bill Weber, Vice President of Integra OrthoBiologics.
Source-Medindia